Injective vs Zilliqa — how do they compare? Injective trades at Rp76,667 (market cap Rp7,62T, Rp1,02T 24h volume), while Zilliqa trades at Rp41.41 (market cap Rp833,99M, Rp70,38M 24h volume). The key difference: Injective is far larger — about 9136.8× Zilliqa's market cap, and Zilliqa's supply is capped (20,1B / 21B ZIL (96%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Zilliqa for 130 Days on average.
| INJ | ZIL | |
|---|---|---|
Market Cap | Rp7,62T | Rp833,99M |
Volume (24h) | Rp1,02T | Rp70,38M |
Circulating Supply | 100M INJ | 20,1B / 21B ZIL (96%) |
Typical Hold Time | 37 Days | 130 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
Zilliqa (ZIL) is currently trading at Rp42.489 with a bearish technical signal, as indicated by moving averages, though oscillators are neutral. The token is near its 52-week low, with key support at Rp40 and resistance at Rp43. On-chain metrics show a high circulation rate of 96%, with an average hold time of 130 days. No major protocol updates or ecosystem developments were reported recently.
Overall outlook remains cautious due to bearish technicals and lack of positive catalysts. Key opportunities include potential rebounds from oversold RSI levels, but risks involve continued downward pressure, low liquidity, and broader crypto market volatility. Investors should monitor for any network upgrades or increased adoption to shift sentiment.
What Pluang investors did over the last 30 days
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Zilliqa (ZIL) is a public, permissionless blockchain that is designed to offer high throughput with the ability to complete thousands of transactions per second. It seeks to solve the issue of blockchain scalability and speed by employing sharding as a second-layer scaling solution. The platform is home to many decentralized applications, and as of October 2020, it also allows for staking and yield farming.
Read more on ZIL →